Black community members, scientists object to plan to bury skulls from Philadelphia museum
By Lizzie Wade,
Science
| 01. 23. 2024
For nearly 2 centuries, the skulls of 20 Black people who died in Philadelphia have formed part of the Morton Cranial Collection, now housed at the University of Pennsylvania (UPenn) Museum of Archaeology and Anthropology. Most of the skulls were collected by physical anthropologist Samuel Morton, who in the 1830s and ’40s amassed hundreds of them for studies he designed to identify supposed biological racial differences and scientifically prove what he believed to be the inferiority of nonwhite people. On 3 February, the museum plans to lay the crania of 19 of the Black Philadelphians in the collection to rest in a historically Black cemetery. “After 200 years of being on display and subject to scientific testing, these individuals deserve an interment with all the dignity and respect that we can give them,” says Penn Museum Director Christopher Woods. “They don’t belong in the museum.”
But a self-identified descendant community group and multiple anthropologists say the museum has not lived up to its promise to repatriate the remains and has failed to do sufficient archival research into the identities of...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...